Cargando…
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
[Image: see text] Introduction: Tumor endothelial marker 1 (TEM1) is expressed by tumor vascular endothelial cells in various cancers. Methods: Here, we developed poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) PEGylated with polyethylene glycol (PEG) and functionalized with anti-TEM1 antib...
Autores principales: | Matthaiou, Efthymia-Iliana, Guo, Yi, Barar, Jaleh, Sandaltzopoulos, Raphael, Kandalaft, Lana E., Li, Chunsheng, Coukos, George, Omidi, Yadollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783079/ https://www.ncbi.nlm.nih.gov/pubmed/35087718 http://dx.doi.org/10.34172/bi.2021.23511 |
Ejemplares similares
-
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2014) -
Immuno-imaging and -therapy in ovarian cancer and sarcoma with de novo single-chain fv-fc fusion protein targeting TEM1/CD248
por: Li, Chunsheng, et al.
Publicado: (2014) -
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014) -
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
por: Barar, Jaleh, et al.
Publicado: (2014) -
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
por: Barar, Jaleh, et al.
Publicado: (2015)